Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mesoblast Limited (MESO) vs Palo Alto Networks Inc (PANW) Price & Performance

Mesoblast LimitedTrade
Palo Alto Networks IncTrade

Price performance (Past 24H)

Key statistics

Mesoblast Limited vs Palo Alto Networks Inc — how do they compare? Mesoblast Limited trades at $16.96 (market cap $2.21B), while Palo Alto Networks Inc trades at $381.5 (market cap $312.80B). The key difference: Palo Alto Networks Inc is far larger — about 141.5× Mesoblast Limited's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.

MESOPANW
Market Cap
$2.21B$312.80B
Sector
TechnologyTechnology
52-Week High
$20.96$385.04
52-Week Low
$12.88$141.67
Enterprise Value
$2.21B$311.76B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mesoblast Limited

No Aura AI signal available yet.

Palo Alto Networks Inc

Palo Alto Networks (PANW) trades at $385.04, up 5.82% over the past day, reflecting strong momentum amid positive sentiment around AI-driven cybersecurity demand. The stock exhibits a bullish technical setup with moving averages supporting the uptrend, while RSI levels suggest potential overbought conditions. Fundamentally, the company reported revenue of $9.22B in 2025 with a net income margin of 7.95%, though valuation ratios like P/E of 333.74 indicate a premium. Recent news highlights record highs following the Black Hat conference and AI platform launches, though a Chinese regulatory review introduces near-term uncertainty.

The outlook for PANW remains positive given robust revenue growth, AI integration, and Wall Street's bullish consensus, but risks include elevated valuation, integration costs from acquisitions, and geopolitical scrutiny. Investors should weigh the company's leadership in cybersecurity against potential volatility from regulatory developments and high expectations priced into the stock.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO

About Palo Alto Networks Inc

Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.

Read more on PANW